Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-30 4:08 pm Sale | 2026-04-28 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Cormorant Asset Management, LP | 950,000 9.710% | -109,331 (-10.32%) | Filing History |
| 2026-02-17 3:02 pm Sale | 2025-12-31 | 13G | BIOAGE LABS INC BIOA | Cormorant Asset Management, LP | 2,040,605 5.690% | -100,000 (-4.67%) | Filing History |
| 2026-02-17 3:02 pm Sale | 2025-12-31 | 13G | RAPPORT THERAPEUTICS INC RAPP | Cormorant Asset Management, LP | 3,027,521 6.350% | -165,000 (-5.17%) | Filing History |
| 2026-02-17 3:01 pm Purchase | 2025-12-31 | 13G | MOONLAKE IMMUNOTHERAPEUTICS CO MLTX | Cormorant Asset Management, LP | 4,355,433 6.100% | 4,355,433 (New Position) | Filing History |
| 2026-02-17 3:00 pm Purchase | 2025-12-31 | 13G | ENGENE HLDGS INC ENGN | Cormorant Asset Management, LP | 4,000,000 5.970% | 4,000,000 (New Position) | Filing History |
| 2026-02-17 3:00 pm Sale | 2025-12-31 | 13G | CABALETTA BIO INC CABA | Cormorant Asset Management, LP | 9,400,000 9.280% | -191,983 (-2.00%) | Filing History |
| 2026-02-06 3:00 pm Unchanged | 2026-01-31 | 13G | BRIGHT MINDS BIOSCIENCES INC C DRUG | Cormorant Asset Management, LP | 1,059,331 10.880% | 0 (Unchanged) | Filing History |
| 2025-12-15 4:19 pm Sale | 2025-12-11 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Cormorant Asset Management, LP | 2,344,971 13.360% | -30,029 (-1.26%) | Filing History |
| 2025-12-08 4:06 pm Sale | 2025-12-04 | 13G | EYEPOINT INC EYPT | Cormorant Asset Management, LP | 8,265,000 9.980% | -60,000 (-0.72%) | Filing History |
| 2025-11-14 1:23 pm Unchanged | 2025-11-03 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Cormorant Asset Management, LP | 2,375,000 12.820% | 0 (Unchanged) | Filing History |
| 2025-11-14 1:10 pm Purchase | 2025-09-30 | 13G | CABALETTA BIO INC CABA | Cormorant Asset Management, LP | 9,591,983 9.990% | 4,591,983 (+91.84%) | Filing History |
| 2025-11-14 1:10 pm Sale | 2025-09-30 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Cormorant Asset Management, LP | 0 0.000% | -27,419 (Position Closed) | Filing History |
| 2025-11-14 1:09 pm Purchase | 2025-09-30 | 13G | RAPPORT THERAPEUTICS INC RAPP | Cormorant Asset Management, LP | 3,192,521 6.700% | 251,600 (+8.56%) | Filing History |
| 2025-11-14 1:08 pm Sale | 2025-09-30 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Cormorant Asset Management, LP | 1,000,000 4.000% | -625,000 (-38.46%) | Filing History |
| 2025-11-14 1:07 pm Sale | 2025-09-30 | 13G | KALA BIO, INC. KALA | Cormorant Asset Management, LP | 0 0.000% | -12,181 (Position Closed) | Filing History |
| 2025-11-14 1:07 pm Purchase | 2025-09-30 | 13G | IBIO INC PAR $0.001 IBIO | Cormorant Asset Management, LP | 2,248,010 9.990% | 2,248,010 (New Position) | Filing History |
| 2025-10-24 4:10 pm Sale | 2025-10-22 | 13D | BIOMEA FUSION INC BMEA | Cormorant Asset Management, LP | 1,060,792 1.530% | -2,620,872 (-71.19%) | Filing History |
| 2025-10-10 4:06 pm Unchanged | 2025-10-08 | 13D | BIOMEA FUSION INC BMEA | Cormorant Asset Management, LP | 3,681,664 5.310% | 0 (Unchanged) | Filing History |
| 2025-08-14 3:04 pm Sale | 2025-06-30 | 13G | VYNE THERAPEUTICS INC PAR$ VYNE | Cormorant Asset Management, LP | 27,419 8.230% | -9,573 (-25.88%) | Filing History |
| 2025-08-14 3:03 pm Sale | 2025-06-30 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Cormorant Asset Management, LP | 1,625,000 7.720% | -120,000 (-6.88%) | Filing History |